Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page
- CheckyesterdayChange DetectedRecent history entries show Study Status updates on 2025-12-22 and 2025-12-23. A deletion entry dated 2025-05-02 appears in the version history for NCT05297890.SummaryDifference0.4%

- Check8 days agoChange DetectedAdded an entry 'Revision: v3.3.3' to the Record History and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new system revision entry v3.3.2 was added to the history, replacing the earlier v3.3.1 entry. This is a release-note level update and does not affect study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision entry v3.3.1 was added to the record history, and the previous revision v3.2.0 was removed from the list.SummaryDifference0.1%

- Check44 days agoChange DetectedDeleted the temporary government funding notice about updates and inquiries during appropriation lapses, which previously warned that the site may be out of date and inquiries delayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check58 days agoChange DetectedA new version entry dated 2025-04-29 was added to the Study Record Versions table. No other page content appears to have changed.SummaryDifference0.1%

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.